Mary Ellen Healy

Mary Ellen Healy has an extensive work experience in the field of clinical operations. Mary Ellen currently holds the position of Vice President Clinical Operations at Tango Therapeutics since January 2023. Their previous role before that was as the Head of Clinical Operations at Beam Therapeutics from June 2020 to January 2023. Mary Ellen also served as the Senior Director of Clinical Operations at Moderna from May 2019 to June 2020. Before that, they worked as the Senior Director of Clinical Operations at Curis from January 2018 to April 2019. Mary Ellen has also held positions as the Director of Clinical Operations at Blueprint Medicines from October 2015 to December 2017, and as Lead CTL (Associate Director) at Novartis from June 2011 to October 2015. Prior to that, they worked as a Clinical Program Manager at Alkermes from June 2008 to May 2011. Mary Ellen started their career as a Clinical Research Manager at IPSEN, Biomeasure, Inc from March 2007 to June 2008. Before that, they had roles at Dana-Farber Cancer Institute, including Clinical Research Project Manager from February 2006 to March 2007, Clinical Trials Monitor and Data Analyst III from July 2003 to February 2006, and Data Analyst II from July 2003 to April 2005. Mary Ellen began their career as a Clinical Research Assistant at PAREXEL International Corporation from April 2002 to March 2003.

Mary Ellen Healy earned a Bachelor of Science degree in Nutritional Sciences from the University of New Hampshire from 1994 to 1999. Mary Ellen then went on to obtain a Master of Science degree in Drug Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and Health Sciences, which they completed from 2005 to 2007.